- Home
- PAA vs QGEN Comparison
PAA vs QGEN Comparison
Compare PAA & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PAA
- QGEN
- Stock Information
- Founded
- PAA 1981
- QGEN 1986
- Country
- PAA United States
- QGEN Netherlands
- Employees
- PAA N/A
- QGEN N/A
- Industry
- PAA Natural Gas Distribution
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PAA Energy
- QGEN Health Care
- Exchange
- PAA Nasdaq
- QGEN Nasdaq
- Market Cap
- PAA 12.1B
- QGEN 10.7B
- IPO Year
- PAA N/A
- QGEN 1996
- Fundamental
- Price
- PAA $17.05
- QGEN $44.31
- Analyst Decision
- PAA Hold
- QGEN Buy
- Analyst Count
- PAA 12
- QGEN 7
- Target Price
- PAA $20.18
- QGEN $50.68
- AVG Volume (30 Days)
- PAA 3.1M
- QGEN 1.2M
- Earning Date
- PAA 11-05-2025
- QGEN 11-04-2025
- Dividend Yield
- PAA 8.97%
- QGEN 3.38%
- EPS Growth
- PAA 7.88
- QGEN 331.20
- EPS
- PAA 1.21
- QGEN 1.84
- Revenue
- PAA $46,917,000,000.00
- QGEN $2,070,781,000.00
- Revenue This Year
- PAA N/A
- QGEN $7.37
- Revenue Next Year
- PAA $5.89
- QGEN $5.65
- P/E Ratio
- PAA $14.00
- QGEN $24.28
- Revenue Growth
- PAA N/A
- QGEN 5.32
- 52 Week Low
- PAA $15.58
- QGEN $37.63
- 52 Week High
- PAA $21.00
- QGEN $51.88
- Technical
- Relative Strength Index (RSI)
- PAA 59.72
- QGEN 39.97
- Support Level
- PAA $16.50
- QGEN $42.82
- Resistance Level
- PAA $16.81
- QGEN $47.39
- Average True Range (ATR)
- PAA 0.33
- QGEN 1.11
- MACD
- PAA 0.05
- QGEN -0.18
- Stochastic Oscillator
- PAA 92.67
- QGEN 26.33
About PAA Plains All American Pipeline L.P.
Plains All American Pipeline LP through its subsidiaries, engages in the pipeline transportation, terminaling, storage, and gathering of crude oil and natural gas liquids (NGL) in the United States and Canada. The company operates through two segments, Crude Oil and NGL. The Crude Oil segment offers gathering and transporting crude oil through pipelines, gathering systems, trucks, and barges or railcars. The NGL segment is involved in natural gas processing and NGL fractionation, storage, transportation, and terminalling. It generates the majority of its revenue from the Crude Oil segment.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).